快而精医药(QGEN)

49.74 0.77 1.5724%

今开:49.5昨收:48.97
最高:49.77 最低:49.42
涨停价:0.0跌停价:0.0
总市值:1.1325798E10

快而精医药的热门评论

快而精医药(QGEN)2020-06-03 05:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-069023 Act: 34 Size: 97 KB 网页链接查看全文

快而精医药(QGEN)2020-05-26 18:15

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-065586 Act: 34 Size: 96 KB 网页链接查看全文

快而精医药(QGEN)2020-05-18 18:30

$快而精医药(QGEN)$ SC 14D9 Solicitation, recommendation statements Accession Number: 0001193125-20-144434 Act: 34 Size: 6 MB 网页链接查看全文

快而精医药(QGEN)2020-05-18 18:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-062859 Act: 34 Size: 7 MB 网页链接查看全文

快而精医药(QGEN)2020-05-11 18:15

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-059001 Act: 34 Size: 3 MB 网页链接查看全文

快而精医药(QGEN)2020-05-08 18:15

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000025 Act: 34 Size: 508 KB 网页链接查看全文

快而精医药(QGEN)2020-05-07 18:15

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000022 Act: 34 Size: 57 KB 网页链接查看全文

快而精医药(QGEN)2020-04-28 18:30

$快而精医药(QGEN)$ SC TO-T Tender offer statement by Third Party Accession Number: 0001104659-20-051835 Act: 34 Size: 2 MB 网页链接查看全文

美股专题:美股医药科技低估成长价值第十八期

源之谷港美股2019-04-11 17:32

文/文白
来源:yuanzhigu
源之谷港美股专注港美股市场医药,科技,严重低估个股的深度研究,让价值重回光明,让科技改变人生,欢迎交流!
@今日话题 @雪盈证券 @江涛
1. 沃特世 WAT
沃特世公司于1991年在特拉华州成立,是一家分析仪器制造商。公司主要从事设计、制造、销售和服...查看全文

快而精医药(QGEN)2020-04-23 18:15

$快而精医药(QGEN)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-20-049906 Act: 34 Size: 37 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

专项披露公告

快而精医药(QGEN)06-01 18:06

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接查看全文

财报披露

快而精医药(QGEN)04-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)04-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接查看全文

定期披露文件

快而精医药(QGEN)03-14 19:36

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接查看全文

年度财报

快而精医药(QGEN)03-14 19:27

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30